Opsoclonus: Its Clinical Value

Overview

Journal Neurology

Specialty Neurology

Date 1975 Jun 1

PMID 1168869

Citations 9

Authors

S N Bellur

Affiliations

Soon will be listed here.

Abstract

Although the exact site of pathologic involvement and the pathogenesis remain uncertain, opsoclonus is an invaluable clinical sign that in it alone may herald an occult systemic malignancy. A thorough systematic evaluation should be undertaken to exclude an occult neoplasm in any patient who presents with opsoclonus unaccompanied by any other clinical sign.

Citing Articles

Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy.

Cannilla H, Messe M, Girardin F, Borruat F, Bally J Tremor Other Hyperkinet Mov (N Y). 2024; 14:23.

PMID: 38737300 PMC: 11086588. DOI: 10.5334/tohm.832.

A review of the therapy of paraneoplastic neurologic syndromes.

Das A, Hochberg F, McNelis S J Neurooncol. 1999; 41(2):181-94.

PMID: 10222439 DOI: 10.1023/a:1006133102928.

Paraneoplastic opsoclonus associated with cancer of the gall bladder.

Corcia P, De Toffol B, Hommet C, Saudeau D, Autret A J Neurol Neurosurg Psychiatry. 1997; 62(3):293.

PMID: 9069495 PMC: 1064169. DOI: 10.1136/jnnp.62.3.293.

Cerebellar ataxia and opsoclonus as the initial manifestations of myoclonic encephalopathy associated with neuroblastoma.

Harel S, Yurgenson U, Rechavi G, Burstein Y, Spirer Z Childs Nerv Syst. 1987; 3(4):245-7.

PMID: 3690566 DOI: 10.1007/BF00274060.

Pontine lesion in opsoclonus-myoclonus syndrome shown by MRI.

Hattori T, Hirayama K, Imai T, Yamada T, Kojima S J Neurol Neurosurg Psychiatry. 1988; 51(12):1572-5.

PMID: 3221225 PMC: 1032776. DOI: 10.1136/jnnp.51.12.1572.